SynchroPET Company

We build the smallest Positron Emission Tomography (PET) Scanners in medical imaging and research. Our first device promises to disrupt the nuclear imaging market by providing a non invasive input function that makes all PET scanners more quantitative and better at diagnosis and treatment of diseases like cancer, alzheimers, and parkinson's. This new quantitative data opens up and accelerates new possibilities in personalized medical treatments and cures.
Technology: P4 Medicine
Industry: Biotechnology, Health Care, Health Diagnostics, Medical Device
Headquarters: Stony Brook, New York, United States
Founded Date: 2013-03-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 5
Total Funding: $9.5M
Last Funding Type: Venture - Series Unknown

Visit Website
marc@synchropet.com
http://twitter.com/SynchroPET
Register and Claim Ownership